Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Eukaryotic translation elongation factor 1 alpha 1 pseudogene 24 (EEF1A1P24)
- Target
- EEF1A1P24
- Molecular classification
- Other (Processed pseudogene)
01
Overview
Eukaryotic translation elongation factor 1 alpha 1 pseudogene 24 (EEF1A1P24) is a processed pseudogene of the protein-coding gene EEF1A1, which encodes a key elongation factor involved in protein synthesis. EEF1A1P24 does not produce a functional protein, but like many pseudogenes, it may be expressed at the RNA level. There are reported associations (not causal relationships) with certain diseases such as acute lymphoblastic leukemia, but no actionable role has been established. As a pseudogene, EEF1A1P24 is primarily of interest to genomics research rather than therapeutics, is not a drug target, and has no known direct clinical or biomarker utility.
- Other names
- EEF1A1P24
02
Mechanism of action
None (not a therapeutically actionable target)
03
Biological functions
None (as a pseudogene, it does not code for a functional protein)
04
Disease associations
Other (Reported to be associated with acute lymphoblastic leukemia, but its function in disease is speculative and not causative)
05
Safety considerations
None known or relevant
06
Interacting drugs
None (pseudogenes do not code for proteins and are not direct drug targets)
07
Biomarkers
None established or in clinical use
Beyond the preview
Go deeper on Eukaryotic translation elongation factor 1 alpha 1 pseudogene 24 (EEF1A1P24).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Eukaryotic translation elongation factor 1 alpha 1 pseudogene 24 (EEF1A1P24).